Treace Medical Concepts, Inc. Basic Shares Outstanding (Weighted Average)
Treace Medical Concepts, Inc. (TMCI) reported Basic Shares Outstanding (Weighted Average) of 65.05 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-07
- Treace Medical Concepts, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 65.05M shares, a 3.24% increase year-over-year.
- Treace Medical Concepts, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 64.59M shares, a 3.08% increase year-over-year.
- Treace Medical Concepts, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 63.87M shares, a 2.45% increase year-over-year.
- Treace Medical Concepts, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 63.52M shares, a 2.07% increase year-over-year.
- Treace Medical Concepts, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 63.27M shares, a 1.86% increase from fiscal 2024.
- Treace Medical Concepts, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 62.11M shares, a 2.07% increase from fiscal 2023.
- Treace Medical Concepts, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 60.85M shares, a 10.09% increase from fiscal 2022.
- Treace Medical Concepts, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 55.28M shares, a 14.17% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 65.05M shares 10-Q · filed 2026-08-07 | 64.82M shares 10-Q · filed 2026-08-07 | 64.50M shares derived: average of 3 quarters · filed 2026-08-07 | 64.26M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 64.59M shares 10-Q · filed 2026-05-08 | 64.23M shares derived: average of 2 quarters · filed 2026-05-08 | 63.99M shares derived: average of 3 quarters · filed 2026-05-08 | 63.75M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | 63.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 63.69M shares derived: average of 2 quarters · filed 2026-02-27 | 63.46M shares derived: average of 3 quarters · filed 2026-08-07 | 63.27M shares 10-K · filed 2026-02-27 |
| 2025-09-30 | 63.52M shares 10-Q · filed 2025-11-06 | 63.26M shares derived: average of 2 quarters · filed 2026-08-07 | 63.07M shares 10-Q · filed 2025-11-06 | 62.88M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | 63.01M shares 10-Q · filed 2026-08-07 | 62.84M shares 10-Q · filed 2026-08-07 | 62.67M shares derived: average of 3 quarters · filed 2026-08-07 | 62.56M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | 62.66M shares 10-Q · filed 2026-05-08 | 62.50M shares derived: average of 2 quarters · filed 2026-05-08 | 62.41M shares derived: average of 3 quarters · filed 2026-05-08 | 62.33M shares derived: average of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | 62.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 62.29M shares derived: average of 2 quarters · filed 2026-02-27 | 62.22M shares derived: average of 3 quarters · filed 2026-02-27 | 62.11M shares 10-K · filed 2026-02-27 |
| 2024-09-30 | 62.23M shares 10-Q · filed 2025-11-06 | 62.16M shares derived: average of 2 quarters · filed 2025-11-06 | 62.04M shares 10-Q · filed 2025-11-06 | 61.95M shares derived: average of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | 62.08M shares 10-Q · filed 2025-08-07 | 61.94M shares 10-Q · filed 2025-08-07 | 61.86M shares derived: average of 3 quarters · filed 2026-02-27 | 61.79M shares derived: average of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | 61.79M shares 10-Q · filed 2025-05-08 | 61.75M shares derived: average of 2 quarters · filed 2026-02-27 | 61.69M shares derived: average of 3 quarters · filed 2026-02-27 | 61.61M shares derived: average of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | 61.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 61.64M shares derived: average of 2 quarters · filed 2026-02-27 | 61.55M shares derived: average of 3 quarters · filed 2026-02-27 | 60.85M shares 10-K · filed 2026-02-27 |
| 2023-09-30 | 61.56M shares 10-Q · filed 2024-11-05 | 61.47M shares derived: average of 2 quarters · filed 2024-11-05 | 60.57M shares 10-Q · filed 2024-11-05 | 59.30M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 61.38M shares 10-Q · filed 2024-08-06 | 60.06M shares 10-Q · filed 2024-08-06 | 58.55M shares derived: average of 3 quarters · filed 2025-02-27 | 57.77M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 58.72M shares 10-Q · filed 2024-05-07 | 57.13M shares derived: average of 2 quarters · filed 2025-02-27 | 56.56M shares derived: average of 3 quarters · filed 2025-02-27 | 56.25M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 55.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 55.48M shares derived: average of 2 quarters · filed 2025-02-27 | 55.42M shares derived: average of 3 quarters · filed 2025-02-27 | 55.28M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 55.43M shares 10-Q · filed 2023-11-09 | 55.37M shares derived: average of 2 quarters · filed 2023-11-09 | 55.19M shares 10-Q · filed 2023-11-09 | 54.85M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | 55.31M shares 10-Q · filed 2023-08-09 | 55.07M shares 10-Q · filed 2023-08-09 | 54.66M shares derived: average of 3 quarters · filed 2024-02-27 | 54.19M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | 54.83M shares 10-Q · filed 2023-05-09 | 54.34M shares derived: average of 2 quarters · filed 2024-02-27 | 53.82M shares derived: average of 3 quarters · filed 2024-02-27 | 52.66M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | 53.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 53.31M shares derived: average of 2 quarters · filed 2024-02-27 | 51.94M shares derived: average of 3 quarters · filed 2024-02-27 | 48.42M shares 10-K · filed 2024-02-27 |
| 2021-09-30 | 52.77M shares 10-Q · filed 2022-11-09 | 50.98M shares derived: average of 2 quarters · filed 2022-11-09 | 46.60M shares 10-Q · filed 2022-11-09 | |
| 2021-06-30 | 49.19M shares 10-Q · filed 2022-08-10 | 43.56M shares 10-Q · filed 2022-08-10 | ||
| 2020-12-31 | 37.07M shares 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |